欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3898/002
药品名称Rivaroxaban Sandoz 15 mg, filmomhulde tabletten
活性成分
    • Rivaroxaban 15.0 mg
剂型Film-coated tablet
上市许可持有人Sandoz B.V. Hospitaaldreef 29, 1315 RC Almere Netherlands
参考成员国 - 产品名称Netherlands (NL)
Rivaroxaban Sandoz 15 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Cyprus (CY)
      Rivaroxaban/Sandoz 15mg film-coated tablet
    • Spain (ES)
    • Iceland (IS)
    • Germany (DE)
    • Denmark (DK)
      Rivaroxaban "Sandoz"
    • Belgium (BE)
      Rivaroxaban Sandoz 15 mg filmomhulde tabletten
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Rivaroxaban Sandoz 15 mg – Filmtabletten
    • France (FR)
    • Portugal (PT)
    • Greece (GR)
      RIVAROXABAN/SANDOZ
    • Sweden (SE)
    • Norway (NO)
      Rivaroxaban Sandoz
    • Finland (FI)
    • Hungary (HU)
      RIVAROXABAN SANDOZ 15 mg filmtabletta
    • Slovakia (SK)
      Rivaroxabán Sandoz 15 mg
    • Malta (MT)
许可日期2017/09/01
最近更新日期2025/09/15
药物ATC编码
    • B01AF01 rivaroxaban
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase